SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-151954
Filing Date
2017-05-01
Accepted
2017-05-01 16:33:26
Documents
53
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d309099d10q.htm 10-Q 338237
2 EX-10.2 d309099dex102.htm EX-10.2 450906
3 EX-31.1 d309099dex311.htm EX-31.1 9769
4 EX-31.2 d309099dex312.htm EX-31.2 9755
5 EX-32.1 d309099dex321.htm EX-32.1 4605
12 GRAPHIC g309099ex102logo.jpg GRAPHIC 13390
  Complete submission text file 0001193125-17-151954.txt   3048224

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rxdx-20170331.xml EX-101.INS 407193
7 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20170331.xsd EX-101.SCH 32687
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxdx-20170331_cal.xml EX-101.CAL 47331
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxdx-20170331_def.xml EX-101.DEF 102941
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20170331_lab.xml EX-101.LAB 308469
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20170331_pre.xml EX-101.PRE 203921
Mailing Address 4545 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4545 TOWNE CENTRE COURT SAN DIEGO CA 92121 (858) 255-5959
Ignyta, Inc. (Filer) CIK: 0001557421 (see all company filings)

IRS No.: 453174872 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36344 | Film No.: 17801234
SIC: 2834 Pharmaceutical Preparations